rs923768

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001354483.2(CSGALNACT1):​c.-391-71587A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.459 in 152,108 control chromosomes in the GnomAD database, including 16,526 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 16526 hom., cov: 33)

Consequence

CSGALNACT1
NM_001354483.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.25

Publications

3 publications found
Variant links:
Genes affected
CSGALNACT1 (HGNC:24290): (chondroitin sulfate N-acetylgalactosaminyltransferase 1) This gene encodes an enzyme that transfers N-acetylglucosamine (GalNAc) to the core tetrasaccharide linker and to elongating chondroitin sulfate chains in proteoglycans. Knockout of the orthologous mouse gene indicates that the protein is necessary for normal cartilage development and aggrecan metabolism. Mutations in this gene are associated with multiple sclerosis progression, and with mild skeletal dysplasia and joint laxity. [provided by RefSeq, Aug 2017]
CSGALNACT1 Gene-Disease associations (from GenCC):
  • skeletal dysplasia, mild, with joint laxity and advanced bone age
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001354483.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.524 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001354483.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSGALNACT1
NM_001354483.2
MANE Select
c.-391-71587A>G
intron
N/ANP_001341412.1Q8TDX6-1
CSGALNACT1
NM_001354475.2
c.-392+41433A>G
intron
N/ANP_001341404.1Q8TDX6-1
CSGALNACT1
NM_001354476.2
c.-391-71587A>G
intron
N/ANP_001341405.1Q8TDX6-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSGALNACT1
ENST00000692225.2
MANE Select
c.-391-71587A>G
intron
N/AENSP00000509853.1Q8TDX6-1
CSGALNACT1
ENST00000332246.10
TSL:1
c.-544+9021A>G
intron
N/AENSP00000330805.6Q8TDX6-1
CSGALNACT1
ENST00000695892.1
c.-504+31309A>G
intron
N/AENSP00000512242.1Q8TDX6-1

Frequencies

GnomAD3 genomes
AF:
0.459
AC:
69731
AN:
151990
Hom.:
16522
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.349
Gnomad AMI
AF:
0.652
Gnomad AMR
AF:
0.447
Gnomad ASJ
AF:
0.512
Gnomad EAS
AF:
0.395
Gnomad SAS
AF:
0.542
Gnomad FIN
AF:
0.439
Gnomad MID
AF:
0.563
Gnomad NFE
AF:
0.523
Gnomad OTH
AF:
0.487
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.459
AC:
69758
AN:
152108
Hom.:
16526
Cov.:
33
AF XY:
0.454
AC XY:
33783
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.349
AC:
14486
AN:
41494
American (AMR)
AF:
0.447
AC:
6831
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.512
AC:
1778
AN:
3470
East Asian (EAS)
AF:
0.395
AC:
2040
AN:
5166
South Asian (SAS)
AF:
0.542
AC:
2615
AN:
4828
European-Finnish (FIN)
AF:
0.439
AC:
4638
AN:
10576
Middle Eastern (MID)
AF:
0.548
AC:
161
AN:
294
European-Non Finnish (NFE)
AF:
0.523
AC:
35567
AN:
67970
Other (OTH)
AF:
0.495
AC:
1047
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1918
3836
5754
7672
9590
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
646
1292
1938
2584
3230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.511
Hom.:
33473
Bravo
AF:
0.452
Asia WGS
AF:
0.488
AC:
1697
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.30
DANN
Benign
0.54
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs923768;
hg19: chr8-19530963;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.